WS
DMK

Wedbush Securities’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Wedbush Securities’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,237
Closed -$61K – 1049
2019
Q3 		$61K Buy
1,237
+600
+94% +$43.1K 0.01% 927
2019
Q2 		$58K Buy
637
+371
+139% +$45.1K 0.01% 940
2019
Q1 		$39K Buy
+266
New +$51.4K ﹤0.01% 907
2017
Q1 		– Sell
-143
Closed -$32K – 892
2016
Q4 		$32K Buy
+143
New +$28.7K ﹤0.01% 792

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wedbush Securities's DMK Position: Q4 2019 in Review

Wedbush Securities sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2019, closing a stake of 1,237 shares — an estimated $61K sold.

Wedbush Securities first reported a position in DMK in Q4 2016 and held it in 4 quarters. The position peaked at $61K in Q3 2019. 38 funds tracked by Wall St. Rank hold DMK as of Q4 2019.

  • Wedbush Securities reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2019 after selling out during the quarter.
  • Wedbush Securities sold 1,237 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2019, an estimated $61K.
  • Wedbush Securities first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2016 and held it in 4 quarters.
  • Wedbush Securities's DMK Pharmaceuticals Corporation Common Stock position peaked at $61K in Q3 2019.
  • 38 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2019.

Based on Wedbush Securities's 13F filing for Q4 2019, filed 16 Jan 2020.